Since 2012, when PACS1-NDD was first characterized, deep phenotyping analysis has allowed us to establish a potential relationship with other neurodevelopmental disorders, such as the PACS2 or Wdr37 syndromes. This evidence concerns the gene PACS1 and Down syndrome.